@article {4242,
	title = {Acute hemolytic transfusion reaction secondary to anti-Fy3.},
	journal = {Immunohematology / American Red Cross//IMMUNOHEMATOLOGY},
	volume = {21},
	year = {2005},
	month = {2005},
	pages = {48 - 52},
	publisher = {Olteanu,H. Department of Pathology, the University of Texas Southwestern Medical Center at Dallas 75390-9073, USA.},
	address = {United States},
	abstract = {A hemolytic transfusion reaction due to anti-Fy3 is reported in an African American patient with no history of sickle cell disease. This 82-year-old African American woman received two units of RBCs for anemia (Hab 7 g/dL) on admission for a left hip fracture. On hospital Day 7, the patient underwent left hip endoprosthesis surgery; she received two units of RBCs on the second postoperative day due to Hb of 6.1 g/dL. Her urine was dark during surgery and postoperatively. Her posttransfusion plasma was red. Her Hb dropped from 8.4 to 6.4 g/dL over 24 hours after the transfusion. Her total bilirubin rose to 4.0 mg/dL, with and LDH value of 1558 U/L and a haptoglobin of 10.9 mg/dL. Both the antibody detection test and the DAT were positive. An anti-Fy3 was identified in the serum and in the eluate. To the best of our knowledge, this is the first case of acute intravascular hemolysis due to anti-Fy3 in a patient without sickle cell disease.},
	keywords = {*Blood Transfusion/ae [Adverse Effects], *Hemolysis/im [Immunology], *Isoantibodies/bl [Blood], Acute Disease, Aged, Aged, 80 and over, Female, Humans, Isoantibodies/im [Immunology], Phenotype},
	isbn = {0894-203X},
	author = {Olteanu, H and Gerber, D and Partridge, K and Sarode, R}
}
